-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ECMXDn1k7aMsr6SxzlVR++Ro2tJd4HJlZZh3qDsmOlU0V83ncOI95fhFBNxy6zr5 GVvrNgewpN5v9l8q4i7htw== 0000950142-04-000531.txt : 20040219 0000950142-04-000531.hdr.sgml : 20040219 20040219171212 ACCESSION NUMBER: 0000950142-04-000531 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20040219 GROUP MEMBERS: JEFFREY THORP GROUP MEMBERS: LANGLEY CAPITAL, LLC GROUP MEMBERS: LANGLEY MANAGEMENT, LLC GROUP MEMBERS: LANGLEY PARTNERS, L.P. FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: LANGLEY PARTNERS LP CENTRAL INDEX KEY: 0001142500 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 535 MADISON AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-850-7528 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000944522 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133671221 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-46031 FILM NUMBER: 04616984 BUSINESS ADDRESS: STREET 1: 4 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 2034984210 MAIL ADDRESS: STREET 1: FOUR SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 FORMER COMPANY: FORMER CONFORMED NAME: ONCORX INC DATE OF NAME CHANGE: 19950615 SC 13G 1 sc13g-vion.txt SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No.)* Vion Pharmaceuticals, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 927624106 (CUSIP Number) February 10, 2004 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 927624106 2 - -------------------------------------------------------------------------------- 1. Name of Reporting Person: Langley Partners, L.P. - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group: (a) [_] (b) [X] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization: Delaware - -------------------------------------------------------------------------------- 5. Sole Voting Power: -0- Number of Shares -------------------------------------------------------- Beneficially 6. Shared Voting Power: 3,238,170 (see Item 4) Owned By Each -------------------------------------------------------- Reporting 7. Sole Dispositive Power: -0- Person With -------------------------------------------------------- 8. Shared Dispositive Power: 3,238,170 (see Item 4) - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person: 3,238,170 - -------------------------------------------------------------------------------- 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares: [_] - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (9): 5.9% - -------------------------------------------------------------------------------- 12. Type of Reporting Person: PN - -------------------------------------------------------------------------------- CUSIP No. 927624106 3 - -------------------------------------------------------------------------------- 1. Name of Reporting Person: Langley Management, LLC - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group: (a) [_] (b) [X] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization: Delaware - -------------------------------------------------------------------------------- 5. Sole Voting Power: -0- Number of Shares -------------------------------------------------------- Beneficially 6. Shared Voting Power: 3,238,170 (see Item 4) Owned By Each -------------------------------------------------------- Reporting 7. Sole Dispositive Power: -0- Person With -------------------------------------------------------- 8. Shared Dispositive Power: 3,238,170 (see Item 4) - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person: 3,238,170 - -------------------------------------------------------------------------------- 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares: [_] - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (9): 5.9% - -------------------------------------------------------------------------------- 12. Type of Reporting Person: OO - -------------------------------------------------------------------------------- CUSIP No. 927624106 4 - -------------------------------------------------------------------------------- 1. Name of Reporting Person: Langley Capital, LLC - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group: (a) [_] (b) [X] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization: Delaware - -------------------------------------------------------------------------------- 5. Sole Voting Power: -0- Number of Shares -------------------------------------------------------- Beneficially 6. Shared Voting Power: 3,238,170 (see Item 4) Owned By Each -------------------------------------------------------- Reporting 7. Sole Dispositive Power: -0- Person With -------------------------------------------------------- 8. Shared Dispositive Power: 3,238,170 (see Item 4) - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person: 3,238,170 - -------------------------------------------------------------------------------- 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares: [_] - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (9): 5.9% - -------------------------------------------------------------------------------- 12. Type of Reporting Person: OO - -------------------------------------------------------------------------------- CUSIP No. 927624106 5 - -------------------------------------------------------------------------------- 1. Name of Reporting Person: Jeffrey Thorp - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group: (a) [_] (b) [X] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization: United States - -------------------------------------------------------------------------------- 5. Sole Voting Power: -0- Number of Shares -------------------------------------------------------- Beneficially 6. Shared Voting Power: 3,238,170 (see Item 4) Owned By Each -------------------------------------------------------- Reporting 7. Sole Dispositive Power: -0- Person With -------------------------------------------------------- 8. Shared Dispositive Power: 3,238,170 (see Item 4) - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person: 3,238,170 - -------------------------------------------------------------------------------- 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares: [_] - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (9): 5.9% - -------------------------------------------------------------------------------- 12. Type of Reporting Person: IN - -------------------------------------------------------------------------------- CUSIP No. 927624106 6 Item 1(a). Name of Issuer: Vion Pharmaceuticals, Inc. (the "Company"). Item 1(b). Address of Issuer's Principal Executive Offices: 4 Science Park New Haven, CT 06511 Item 2(a). Name of Persons Filing: (i) Langley Partners, L.P. ("Langley L.P."), (ii) Langley Management, LLC, (iii) Langley Capital, LLC and (iv) Jeffrey Thorp ("Thorp", together with Langley L.P., Langley Management, LLC and Langley Capital, LLC, the "Reporting Persons"). Item 2(b). Address of Principal Business Office: For each Reporting Person: 535 Madison Avenue 7th Floor New York, NY 10022. Item 2(c). Citizenship: See row 4 of each Reporting Person's cover page. Item 2(d). Title of Class of Securities: Common Stock, $.01 par value per share, of the Company Item 2(e). CUSIP Number: 927624106 Item 3. Not applicable. Item 4. Ownership. For each Reporting Person: (a) Amount beneficially owned: 3,238,170 shares of Common Stock as follows: (i) 1,200,000 shares of Common Stock are owned of record by Langley L.P. and (ii) 2,038,170 shares of Common Stock issuable to Langley L.P. upon exercise of warrants. CUSIP No. 927624106 7 Langley Capital, LLC is the general partner of Langley L.P. Thorp is the sole member and manager of Langley Capital, LLC. Langley Management, LLC is the investment manager of Langley L.P. Thorp holds a 99.9% membership interest in Langley Management, LLC and is the sole manager thereof. As a result, each of Langley Management, LLC, Langley Capital, LLC and Thorp are considered to share the power to vote or direct the vote of, and the power to dispose or direct the disposition of, the shares of Common Stock directly beneficially owned by Langley L.P. This statement on Schedule 13G shall not be construed as an admission that any of the Reporting Persons (other than Langley L.P.) is the beneficial owner of the Common Stock covered by this statement. (b) Percent of class: 5.9% of the total outstanding shares of Common Stock. This percentage is based upon the 54,863,219 shares of Common Stock issued and outstanding, which number is calculated by adding (i) 39,271,203 (the number of shares of Common Stock reported in the Company's Form 10-Q/A for the period ended September 30, 2003), (ii) 2,038,170 (the number of shares of Common Stock issuable to Langley L.P. upon exercise of its warrants) and (iii) 13,553,846 (the number of shares of Common Stock issued to certain purchasers (including Langley L.P.) as reported in the Company's Form 8-K, filed on February 11, 2004). (c) Number of shares to which each Reporting Person has: (i) Sole power to vote or direct the vote: -0- (ii) Shared power to vote or direct the vote: 3,238,170 (iii) Sole power to dispose or to direct the disposition of: -0- (iv) Shared power to dispose of or direct the disposition of: 3,238,170 Item 5. Ownership of Five Percent or Less of a Class. Not Applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not Applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported By the Parent Holding Company. Not Applicable. Item 8. Identification and Classification of Members of the Group. Not Applicable. CUSIP No. 927624106 8 Item 9. Notice of Dissolution of a Group. Not Applicable. Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 19, 2004 LANGLEY PARTNERS, L.P. By: LANGLEY CAPITAL, LLC, as General Partner By: /s/ Jeffrey Thorp --------------------------------------- Jeffrey Thorp, Manager LANGLEY MANAGEMENT, LLC By: /s/ Jeffrey Thorp --------------------------------------- Jeffrey Thorp, Manager LANGLEY CAPITAL, LLC By: /s/ Jeffrey Thorp --------------------------------------- Jeffrey Thorp, Manager /s/ Jeffrey Thorp ------------------------------------------- Jeffrey Thorp EX-99 4 ex1_sc13g-vion.txt EXHIBIT 1 EXHIBIT 1 --------- JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, par value $0.01 per share, of Vion Pharmaceuticals, Inc., and further agree that this Joint Filing Agreement shall be included as an exhibit to such joint filings. The undersigned further agree that each party hereto is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein; provided, however, that no party is responsible for the completeness or accuracy of the information concerning any other party making the filing, unless such party knows or has reason to believe that such information is inaccurate. IN WITNESS WHEREOF, the parties have executed this Joint Filing Agreement on February 19, 2004. LANGLEY PARTNERS, L.P. By: LANGLEY CAPITAL, LLC, as General Partner By: /s/ Jeffrey Thorp --------------------------------------- Jeffrey Thorp, Manager LANGLEY MANAGEMENT, LLC By: /s/ Jeffrey Thorp --------------------------------------- Jeffrey Thorp, Manager LANGLEY CAPITAL, LLC By: /s/ Jeffrey Thorp --------------------------------------- Jeffrey Thorp, Manager /s/ Jeffrey Thorp ------------------------------------------- Jeffrey Thorp -----END PRIVACY-ENHANCED MESSAGE-----